nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine triphosphate—ABCB11—Vincristine—muscle cancer	0.115	0.244	CbGbCtD
Adenosine triphosphate—ABCB11—Doxorubicin—muscle cancer	0.0721	0.153	CbGbCtD
Adenosine triphosphate—ABCC2—Vincristine—muscle cancer	0.0607	0.128	CbGbCtD
Adenosine triphosphate—ABCC2—Etoposide—muscle cancer	0.0556	0.118	CbGbCtD
Adenosine triphosphate—ABCC2—Doxorubicin—muscle cancer	0.0379	0.0802	CbGbCtD
Adenosine triphosphate—ABCC2—Methotrexate—muscle cancer	0.0367	0.0777	CbGbCtD
Adenosine triphosphate—ABCB1—Dactinomycin—muscle cancer	0.0321	0.0679	CbGbCtD
Adenosine triphosphate—ABCB1—Vincristine—muscle cancer	0.0198	0.0418	CbGbCtD
Adenosine triphosphate—ABCB1—Etoposide—muscle cancer	0.0181	0.0383	CbGbCtD
Adenosine triphosphate—ACVR1—pes—muscle cancer	0.0151	0.0586	CbGeAlD
Adenosine triphosphate—ABCB1—Doxorubicin—muscle cancer	0.0124	0.0261	CbGbCtD
Adenosine triphosphate—ABCB1—Methotrexate—muscle cancer	0.012	0.0253	CbGbCtD
Adenosine triphosphate—AKT1—hindlimb—muscle cancer	0.00577	0.0224	CbGeAlD
Adenosine triphosphate—AKT1—appendage—muscle cancer	0.00495	0.0192	CbGeAlD
Adenosine triphosphate—CDK15—head—muscle cancer	0.00273	0.0106	CbGeAlD
Adenosine triphosphate—CDK15—testis—muscle cancer	0.00264	0.0103	CbGeAlD
Adenosine triphosphate—ACVR1B—embryo—muscle cancer	0.0026	0.0101	CbGeAlD
Adenosine triphosphate—HSPA1A—Vindesine—Vincristine—muscle cancer	0.00246	0.297	CbGdCrCtD
Adenosine triphosphate—AMHR2—testis—muscle cancer	0.00244	0.00947	CbGeAlD
Adenosine triphosphate—ACVRL1—smooth muscle tissue—muscle cancer	0.00241	0.00936	CbGeAlD
Adenosine triphosphate—APAF1—testis—muscle cancer	0.00235	0.00914	CbGeAlD
Adenosine triphosphate—ALK—embryo—muscle cancer	0.0023	0.00893	CbGeAlD
Adenosine triphosphate—ABCC9—smooth muscle tissue—muscle cancer	0.00229	0.0089	CbGeAlD
Adenosine triphosphate—HSPA1A—smooth muscle tissue—muscle cancer	0.00225	0.00874	CbGeAlD
Adenosine triphosphate—ACVRL1—cardiac atrium—muscle cancer	0.00208	0.00807	CbGeAlD
Adenosine triphosphate—ABCG1—cardiac atrium—muscle cancer	0.00208	0.00807	CbGeAlD
Adenosine triphosphate—ARAF—renal system—muscle cancer	0.00203	0.00787	CbGeAlD
Adenosine triphosphate—ADRBK1—embryo—muscle cancer	0.002	0.00776	CbGeAlD
Adenosine triphosphate—ADRBK2—tendon—muscle cancer	0.002	0.00776	CbGeAlD
Adenosine triphosphate—ASNA1—smooth muscle tissue—muscle cancer	0.00197	0.00767	CbGeAlD
Adenosine triphosphate—ACVR1B—renal system—muscle cancer	0.00197	0.00764	CbGeAlD
Adenosine triphosphate—HSPA1B—cardiac atrium—muscle cancer	0.00194	0.00753	CbGeAlD
Adenosine triphosphate—HSPA1A—cardiac atrium—muscle cancer	0.00194	0.00753	CbGeAlD
Adenosine triphosphate—ADRBK2—bone marrow—muscle cancer	0.00193	0.00751	CbGeAlD
Adenosine triphosphate—NAE1—smooth muscle tissue—muscle cancer	0.0019	0.00738	CbGeAlD
Adenosine triphosphate—ASNA1—renal system—muscle cancer	0.0019	0.00738	CbGeAlD
Adenosine triphosphate—AFG3L2—renal system—muscle cancer	0.00188	0.00729	CbGeAlD
Adenosine triphosphate—ADRBK2—vagina—muscle cancer	0.00185	0.0072	CbGeAlD
Adenosine triphosphate—NAE1—renal system—muscle cancer	0.00183	0.00711	CbGeAlD
Adenosine triphosphate—ARAF—cardiac atrium—muscle cancer	0.00181	0.00705	CbGeAlD
Adenosine triphosphate—ABCG1—tendon—muscle cancer	0.00181	0.00704	CbGeAlD
Adenosine triphosphate—ACVRL1—tendon—muscle cancer	0.00181	0.00704	CbGeAlD
Adenosine triphosphate—ADRBK2—head—muscle cancer	0.00171	0.00665	CbGeAlD
Adenosine triphosphate—SLC25A4—renal system—muscle cancer	0.0017	0.00662	CbGeAlD
Adenosine triphosphate—ASNA1—cardiac atrium—muscle cancer	0.0017	0.00661	CbGeAlD
Adenosine triphosphate—HSPA1B—tendon—muscle cancer	0.00169	0.00657	CbGeAlD
Adenosine triphosphate—HSPA1A—tendon—muscle cancer	0.00169	0.00657	CbGeAlD
Adenosine triphosphate—ACVRL1—vagina—muscle cancer	0.00168	0.00653	CbGeAlD
Adenosine triphosphate—ABCG1—vagina—muscle cancer	0.00168	0.00653	CbGeAlD
Adenosine triphosphate—AFG3L2—cardiac atrium—muscle cancer	0.00168	0.00653	CbGeAlD
Adenosine triphosphate—ADRBK2—testis—muscle cancer	0.00165	0.00642	CbGeAlD
Adenosine triphosphate—AKT1—embryo—muscle cancer	0.00164	0.00638	CbGeAlD
Adenosine triphosphate—NAE1—cardiac atrium—muscle cancer	0.00164	0.00637	CbGeAlD
Adenosine triphosphate—HSPA1B—bone marrow—muscle cancer	0.00164	0.00636	CbGeAlD
Adenosine triphosphate—HSPA1A—bone marrow—muscle cancer	0.00164	0.00636	CbGeAlD
Adenosine triphosphate—ARAF—tendon—muscle cancer	0.00158	0.00614	CbGeAlD
Adenosine triphosphate—ADRBK1—smooth muscle tissue—muscle cancer	0.00157	0.0061	CbGeAlD
Adenosine triphosphate—HSPA1B—vagina—muscle cancer	0.00157	0.00609	CbGeAlD
Adenosine triphosphate—HSPA1A—vagina—muscle cancer	0.00157	0.00609	CbGeAlD
Adenosine triphosphate—ACVRL1—head—muscle cancer	0.00155	0.00603	CbGeAlD
Adenosine triphosphate—HSPA1A—Podofilox—Etoposide—muscle cancer	0.00155	0.187	CbGdCrCtD
Adenosine triphosphate—NT5C2—smooth muscle tissue—muscle cancer	0.00154	0.00597	CbGeAlD
Adenosine triphosphate—ARAF—bone marrow—muscle cancer	0.00153	0.00595	CbGeAlD
Adenosine triphosphate—SLC25A4—cardiac atrium—muscle cancer	0.00153	0.00593	CbGeAlD
Adenosine triphosphate—ADRBK1—renal system—muscle cancer	0.00151	0.00587	CbGeAlD
Adenosine triphosphate—ACSS1—renal system—muscle cancer	0.00151	0.00587	CbGeAlD
Adenosine triphosphate—ADCY1—head—muscle cancer	0.0015	0.00585	CbGeAlD
Adenosine triphosphate—ABCG1—testis—muscle cancer	0.0015	0.00583	CbGeAlD
Adenosine triphosphate—ACVRL1—testis—muscle cancer	0.0015	0.00583	CbGeAlD
Adenosine triphosphate—ABCA1—renal system—muscle cancer	0.0015	0.00581	CbGeAlD
Adenosine triphosphate—ASNA1—tendon—muscle cancer	0.00148	0.00576	CbGeAlD
Adenosine triphosphate—ACVR1—renal system—muscle cancer	0.00148	0.00575	CbGeAlD
Adenosine triphosphate—NT5C2—renal system—muscle cancer	0.00148	0.00575	CbGeAlD
Adenosine triphosphate—ARAF—vagina—muscle cancer	0.00147	0.0057	CbGeAlD
Adenosine triphosphate—AFG3L2—tendon—muscle cancer	0.00146	0.00569	CbGeAlD
Adenosine triphosphate—ADCY1—testis—muscle cancer	0.00145	0.00565	CbGeAlD
Adenosine triphosphate—ACSS2—renal system—muscle cancer	0.00145	0.00563	CbGeAlD
Adenosine triphosphate—ACSL1—renal system—muscle cancer	0.00144	0.00559	CbGeAlD
Adenosine triphosphate—ASNA1—bone marrow—muscle cancer	0.00144	0.00558	CbGeAlD
Adenosine triphosphate—NAE1—tendon—muscle cancer	0.00143	0.00555	CbGeAlD
Adenosine triphosphate—ABCC9—testis—muscle cancer	0.00143	0.00554	CbGeAlD
Adenosine triphosphate—AFG3L2—bone marrow—muscle cancer	0.00142	0.00551	CbGeAlD
Adenosine triphosphate—HSPA1B—testis—muscle cancer	0.0014	0.00544	CbGeAlD
Adenosine triphosphate—HSPA1A—testis—muscle cancer	0.0014	0.00544	CbGeAlD
Adenosine triphosphate—NAE1—bone marrow—muscle cancer	0.00138	0.00538	CbGeAlD
Adenosine triphosphate—ASNA1—vagina—muscle cancer	0.00138	0.00535	CbGeAlD
Adenosine triphosphate—PRKAA1—renal system—muscle cancer	0.00136	0.00529	CbGeAlD
Adenosine triphosphate—AFG3L2—vagina—muscle cancer	0.00136	0.00528	CbGeAlD
Adenosine triphosphate—ARAF—head—muscle cancer	0.00135	0.00526	CbGeAlD
Adenosine triphosphate—ACSS1—cardiac atrium—muscle cancer	0.00135	0.00526	CbGeAlD
Adenosine triphosphate—SLC25A4—tendon—muscle cancer	0.00133	0.00517	CbGeAlD
Adenosine triphosphate—NAE1—vagina—muscle cancer	0.00133	0.00515	CbGeAlD
Adenosine triphosphate—ACVR1—cardiac atrium—muscle cancer	0.00132	0.00515	CbGeAlD
Adenosine triphosphate—ACVR1B—head—muscle cancer	0.00132	0.00511	CbGeAlD
Adenosine triphosphate—ARAF—testis—muscle cancer	0.00131	0.00509	CbGeAlD
Adenosine triphosphate—ACSS2—cardiac atrium—muscle cancer	0.0013	0.00504	CbGeAlD
Adenosine triphosphate—AKT1—smooth muscle tissue—muscle cancer	0.00129	0.00502	CbGeAlD
Adenosine triphosphate—ASNS—smooth muscle tissue—muscle cancer	0.00129	0.00502	CbGeAlD
Adenosine triphosphate—ACSL1—cardiac atrium—muscle cancer	0.00129	0.00501	CbGeAlD
Adenosine triphosphate—ASNA1—head—muscle cancer	0.00127	0.00494	CbGeAlD
Adenosine triphosphate—ACVR1B—testis—muscle cancer	0.00127	0.00494	CbGeAlD
Adenosine triphosphate—AFG3L2—head—muscle cancer	0.00125	0.00488	CbGeAlD
Adenosine triphosphate—AKT1—renal system—muscle cancer	0.00124	0.00483	CbGeAlD
Adenosine triphosphate—SLC25A4—vagina—muscle cancer	0.00123	0.0048	CbGeAlD
Adenosine triphosphate—ASNA1—testis—muscle cancer	0.00123	0.00477	CbGeAlD
Adenosine triphosphate—NAE1—head—muscle cancer	0.00122	0.00476	CbGeAlD
Adenosine triphosphate—AFG3L2—testis—muscle cancer	0.00121	0.00471	CbGeAlD
Adenosine triphosphate—NAE1—testis—muscle cancer	0.00118	0.00459	CbGeAlD
Adenosine triphosphate—ACSS1—tendon—muscle cancer	0.00118	0.00458	CbGeAlD
Adenosine triphosphate—ALK—head—muscle cancer	0.00116	0.00452	CbGeAlD
Adenosine triphosphate—ACVR1—tendon—muscle cancer	0.00115	0.00449	CbGeAlD
Adenosine triphosphate—NT5C2—tendon—muscle cancer	0.00115	0.00449	CbGeAlD
Adenosine triphosphate—ADRBK1—bone marrow—muscle cancer	0.00114	0.00444	CbGeAlD
Adenosine triphosphate—ACSS1—bone marrow—muscle cancer	0.00114	0.00444	CbGeAlD
Adenosine triphosphate—SLC25A4—head—muscle cancer	0.00114	0.00443	CbGeAlD
Adenosine triphosphate—ACSS2—tendon—muscle cancer	0.00113	0.0044	CbGeAlD
Adenosine triphosphate—ASS1—smooth muscle tissue—muscle cancer	0.00113	0.00438	CbGeAlD
Adenosine triphosphate—ALK—testis—muscle cancer	0.00112	0.00437	CbGeAlD
Adenosine triphosphate—ACSL1—tendon—muscle cancer	0.00112	0.00437	CbGeAlD
Adenosine triphosphate—ACVR1—bone marrow—muscle cancer	0.00112	0.00435	CbGeAlD
Adenosine triphosphate—NT5C2—bone marrow—muscle cancer	0.00112	0.00435	CbGeAlD
Adenosine triphosphate—TNK2—head—muscle cancer	0.00112	0.00435	CbGeAlD
Adenosine triphosphate—AKT1—cardiac atrium—muscle cancer	0.00111	0.00433	CbGeAlD
Adenosine triphosphate—ASNS—cardiac atrium—muscle cancer	0.00111	0.00433	CbGeAlD
Adenosine triphosphate—ABL2—tendon—muscle cancer	0.0011	0.00428	CbGeAlD
Adenosine triphosphate—SLC25A4—testis—muscle cancer	0.0011	0.00428	CbGeAlD
Adenosine triphosphate—ACSS2—bone marrow—muscle cancer	0.0011	0.00426	CbGeAlD
Adenosine triphosphate—ACSS1—vagina—muscle cancer	0.00109	0.00425	CbGeAlD
Adenosine triphosphate—ADRBK1—vagina—muscle cancer	0.00109	0.00425	CbGeAlD
Adenosine triphosphate—ACSL1—bone marrow—muscle cancer	0.00109	0.00423	CbGeAlD
Adenosine triphosphate—ASS1—renal system—muscle cancer	0.00108	0.00421	CbGeAlD
Adenosine triphosphate—ABCA1—vagina—muscle cancer	0.00108	0.00421	CbGeAlD
Adenosine triphosphate—TNK2—testis—muscle cancer	0.00108	0.0042	CbGeAlD
Adenosine triphosphate—NT5C2—vagina—muscle cancer	0.00107	0.00416	CbGeAlD
Adenosine triphosphate—ACVR1—vagina—muscle cancer	0.00107	0.00416	CbGeAlD
Adenosine triphosphate—HSPA1A—Vinblastine—Vincristine—muscle cancer	0.00107	0.129	CbGdCrCtD
Adenosine triphosphate—ACSS2—vagina—muscle cancer	0.00105	0.00408	CbGeAlD
Adenosine triphosphate—ACSL1—vagina—muscle cancer	0.00104	0.00405	CbGeAlD
Adenosine triphosphate—PRKAA1—bone marrow—muscle cancer	0.00103	0.004	CbGeAlD
Adenosine triphosphate—ABL2—vagina—muscle cancer	0.00102	0.00397	CbGeAlD
Adenosine triphosphate—ADRBK1—head—muscle cancer	0.00101	0.00393	CbGeAlD
Adenosine triphosphate—ACSS1—head—muscle cancer	0.00101	0.00393	CbGeAlD
Adenosine triphosphate—ABCA1—head—muscle cancer	0.001	0.00389	CbGeAlD
Adenosine triphosphate—NT5C2—head—muscle cancer	0.00099	0.00385	CbGeAlD
Adenosine triphosphate—ACVR1—head—muscle cancer	0.00099	0.00385	CbGeAlD
Adenosine triphosphate—ADK—smooth muscle tissue—muscle cancer	0.000983	0.00382	CbGeAlD
Adenosine triphosphate—ACSS1—testis—muscle cancer	0.000977	0.0038	CbGeAlD
Adenosine triphosphate—ADRBK1—testis—muscle cancer	0.000977	0.0038	CbGeAlD
Adenosine triphosphate—ASS1—cardiac atrium—muscle cancer	0.000971	0.00377	CbGeAlD
Adenosine triphosphate—AKT1—tendon—muscle cancer	0.000971	0.00377	CbGeAlD
Adenosine triphosphate—ASNS—tendon—muscle cancer	0.000971	0.00377	CbGeAlD
Adenosine triphosphate—ACSS2—head—muscle cancer	0.00097	0.00377	CbGeAlD
Adenosine triphosphate—ABCA1—testis—muscle cancer	0.000966	0.00375	CbGeAlD
Adenosine triphosphate—ACSL1—head—muscle cancer	0.000963	0.00374	CbGeAlD
Adenosine triphosphate—NT5C2—testis—muscle cancer	0.000956	0.00371	CbGeAlD
Adenosine triphosphate—ACVR1—testis—muscle cancer	0.000956	0.00371	CbGeAlD
Adenosine triphosphate—ADK—renal system—muscle cancer	0.000947	0.00368	CbGeAlD
Adenosine triphosphate—AKT1—bone marrow—muscle cancer	0.00094	0.00365	CbGeAlD
Adenosine triphosphate—ASNS—bone marrow—muscle cancer	0.00094	0.00365	CbGeAlD
Adenosine triphosphate—ACSS2—testis—muscle cancer	0.000937	0.00364	CbGeAlD
Adenosine triphosphate—ACSL1—testis—muscle cancer	0.000931	0.00362	CbGeAlD
Adenosine triphosphate—ABL2—testis—muscle cancer	0.000913	0.00355	CbGeAlD
Adenosine triphosphate—ABCC8—smooth muscle tissue—muscle cancer	0.000912	0.00354	CbGeAlD
Adenosine triphosphate—PRKAA1—head—muscle cancer	0.000912	0.00354	CbGeAlD
Adenosine triphosphate—ASNS—vagina—muscle cancer	0.000901	0.0035	CbGeAlD
Adenosine triphosphate—AKT1—vagina—muscle cancer	0.000901	0.0035	CbGeAlD
Adenosine triphosphate—ABL1—embryo—muscle cancer	0.0009	0.0035	CbGeAlD
Adenosine triphosphate—PRKAA1—testis—muscle cancer	0.000881	0.00342	CbGeAlD
Adenosine triphosphate—ABCC8—renal system—muscle cancer	0.000878	0.00341	CbGeAlD
Adenosine triphosphate—ADK—cardiac atrium—muscle cancer	0.000848	0.00329	CbGeAlD
Adenosine triphosphate—ASS1—tendon—muscle cancer	0.000846	0.00329	CbGeAlD
Adenosine triphosphate—AKT1—head—muscle cancer	0.000832	0.00323	CbGeAlD
Adenosine triphosphate—AKT1—testis—muscle cancer	0.000804	0.00312	CbGeAlD
Adenosine triphosphate—ASNS—testis—muscle cancer	0.000804	0.00312	CbGeAlD
Adenosine triphosphate—ASS1—vagina—muscle cancer	0.000785	0.00305	CbGeAlD
Adenosine triphosphate—ABCB11—testis—muscle cancer	0.000749	0.00291	CbGeAlD
Adenosine triphosphate—HSPA1A—Daunorubicin—Doxorubicin—muscle cancer	0.000749	0.0904	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Idarubicin—Doxorubicin—muscle cancer	0.000749	0.0904	CbGdCrCtD
Adenosine triphosphate—ADK—tendon—muscle cancer	0.000739	0.00287	CbGeAlD
Adenosine triphosphate—ASS1—head—muscle cancer	0.000725	0.00282	CbGeAlD
Adenosine triphosphate—ADK—bone marrow—muscle cancer	0.000716	0.00278	CbGeAlD
Adenosine triphosphate—ABL1—smooth muscle tissue—muscle cancer	0.000708	0.00275	CbGeAlD
Adenosine triphosphate—ASS1—testis—muscle cancer	0.000701	0.00272	CbGeAlD
Adenosine triphosphate—ADK—vagina—muscle cancer	0.000686	0.00266	CbGeAlD
Adenosine triphosphate—ABL1—renal system—muscle cancer	0.000681	0.00265	CbGeAlD
Adenosine triphosphate—ADK—head—muscle cancer	0.000633	0.00246	CbGeAlD
Adenosine triphosphate—ADK—testis—muscle cancer	0.000612	0.00238	CbGeAlD
Adenosine triphosphate—ABL1—cardiac atrium—muscle cancer	0.00061	0.00237	CbGeAlD
Adenosine triphosphate—ABCC2—renal system—muscle cancer	0.000589	0.00229	CbGeAlD
Adenosine triphosphate—ABCC8—head—muscle cancer	0.000588	0.00228	CbGeAlD
Adenosine triphosphate—ABCC8—testis—muscle cancer	0.000568	0.0022	CbGeAlD
Adenosine triphosphate—ABL1—Epirubicin—Doxorubicin—muscle cancer	0.000567	0.0685	CbGdCrCtD
Adenosine triphosphate—ABL1—Idarubicin—Doxorubicin—muscle cancer	0.000567	0.0685	CbGdCrCtD
Adenosine triphosphate—ABL1—Daunorubicin—Doxorubicin—muscle cancer	0.000567	0.0685	CbGdCrCtD
Adenosine triphosphate—ABL1—tendon—muscle cancer	0.000532	0.00207	CbGeAlD
Adenosine triphosphate—ABL1—bone marrow—muscle cancer	0.000515	0.002	CbGeAlD
Adenosine triphosphate—ABL1—vagina—muscle cancer	0.000493	0.00192	CbGeAlD
Adenosine triphosphate—ABCC2—tendon—muscle cancer	0.00046	0.00179	CbGeAlD
Adenosine triphosphate—ABL1—head—muscle cancer	0.000456	0.00177	CbGeAlD
Adenosine triphosphate—ABL1—testis—muscle cancer	0.00044	0.00171	CbGeAlD
Adenosine triphosphate—ABCC2—testis—muscle cancer	0.000381	0.00148	CbGeAlD
Adenosine triphosphate—ABCB1—embryo—muscle cancer	0.00028	0.00109	CbGeAlD
Adenosine triphosphate—ABCB1—renal system—muscle cancer	0.000212	0.000823	CbGeAlD
Adenosine triphosphate—ABCB1—bone marrow—muscle cancer	0.00016	0.000622	CbGeAlD
Adenosine triphosphate—ABCB1—vagina—muscle cancer	0.000153	0.000596	CbGeAlD
Adenosine triphosphate—ABCB1—head—muscle cancer	0.000142	0.000551	CbGeAlD
Adenosine triphosphate—ABCB1—testis—muscle cancer	0.000137	0.000532	CbGeAlD
Adenosine triphosphate—AKT1—Signaling by FGFR in disease—KIT—muscle cancer	0.00012	0.000457	CbGpPWpGaD
Adenosine triphosphate—AKT1—DAP12 interactions—KIT—muscle cancer	0.00012	0.000457	CbGpPWpGaD
Adenosine triphosphate—AKT1—Fc epsilon receptor (FCERI) signaling—KIT—muscle cancer	0.00012	0.000457	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—MED12—muscle cancer	0.000119	0.000456	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by EGFR—KIT—muscle cancer	0.000118	0.000453	CbGpPWpGaD
Adenosine triphosphate—ABL2—Axon guidance—VEGFA—muscle cancer	0.000118	0.000453	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Developmental Biology—VEGFA—muscle cancer	0.000118	0.00045	CbGpPWpGaD
Adenosine triphosphate—AKT1—Rac1/Pak1/p38/MMP-2 pathway—TP53—muscle cancer	0.000117	0.00045	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by EGFR in Cancer—KIT—muscle cancer	0.000117	0.000449	CbGpPWpGaD
Adenosine triphosphate—ABCA1—Metabolism—MED12—muscle cancer	0.000117	0.000448	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by PDGF—KIT—muscle cancer	0.000117	0.000447	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—CD34—muscle cancer	0.000117	0.000447	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—CD34—muscle cancer	0.000117	0.000446	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—FOXO4—muscle cancer	0.000116	0.000444	CbGpPWpGaD
Adenosine triphosphate—AKT1—p75(NTR)-mediated signaling—TP53—muscle cancer	0.000115	0.000439	CbGpPWpGaD
Adenosine triphosphate—AKT1—AMPK Signaling—TP53—muscle cancer	0.000115	0.000439	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—CNR1—muscle cancer	0.000114	0.000436	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by SCF-KIT—MDM2—muscle cancer	0.000113	0.000432	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—CD34—muscle cancer	0.000112	0.000428	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.000112	0.000428	CbGpPWpGaD
Adenosine triphosphate—HSPA1B—Disease—FOXO1—muscle cancer	0.000111	0.000424	CbGpPWpGaD
Adenosine triphosphate—AKT1—B Cell Activation—KIT—muscle cancer	0.000111	0.000423	CbGpPWpGaD
Adenosine triphosphate—ABL1—DNA Damage Response—TP53—muscle cancer	0.00011	0.000421	CbGpPWpGaD
Adenosine triphosphate—AKT1—Downstream signaling of activated FGFR—MDM2—muscle cancer	0.000108	0.000413	CbGpPWpGaD
Adenosine triphosphate—AKT1—VEGFA-VEGFR2 Pathway—VEGFA—muscle cancer	0.000107	0.000409	CbGpPWpGaD
Adenosine triphosphate—AKT1—Integrated Breast Cancer Pathway—MDM2—muscle cancer	0.000107	0.000409	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by NGF—FOXO1—muscle cancer	0.000107	0.000409	CbGpPWpGaD
Adenosine triphosphate—ABCA1—Metabolism—ENO2—muscle cancer	0.000107	0.000409	CbGpPWpGaD
Adenosine triphosphate—ABL1—miRNA Regulation of DNA Damage Response—TP53—muscle cancer	0.000106	0.000407	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by ERBB4—MDM2—muscle cancer	0.000106	0.000407	CbGpPWpGaD
Adenosine triphosphate—AKT1—NGF signalling via TRKA from the plasma membrane—KIT—muscle cancer	0.000106	0.000405	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by NGF—MDM2—muscle cancer	0.000106	0.000405	CbGpPWpGaD
Adenosine triphosphate—ACSL1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	0.000104	0.000398	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Neuronal System—MDM2—muscle cancer	0.000103	0.000396	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Disease—FOXO1—muscle cancer	0.000102	0.000391	CbGpPWpGaD
Adenosine triphosphate—AKT1—Downstream signal transduction—MDM2—muscle cancer	0.000102	0.000389	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by NGF—MDM2—muscle cancer	0.000101	0.000388	CbGpPWpGaD
Adenosine triphosphate—ABL1—Integrated Breast Cancer Pathway—MDM2—muscle cancer	0.000101	0.000388	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—FH—muscle cancer	0.000101	0.000387	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by FGFR—MDM2—muscle cancer	0.000101	0.000387	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—PTCH1—muscle cancer	0.000101	0.000386	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by VEGF—VEGFA—muscle cancer	0.000101	0.000386	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Innate Immune System—FOXO1—muscle cancer	0.000101	0.000385	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by ERBB2—MDM2—muscle cancer	0.000101	0.000385	CbGpPWpGaD
Adenosine triphosphate—AKT1—DAP12 signaling—MDM2—muscle cancer	0.0001	0.000383	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways in Glioblastoma—TP53—muscle cancer	9.99e-05	0.000382	CbGpPWpGaD
Adenosine triphosphate—AKT1—Glucocorticoid receptor regulatory network—TP53—muscle cancer	9.99e-05	0.000382	CbGpPWpGaD
Adenosine triphosphate—AKT1—Downstream signaling events of B Cell Receptor (BCR)—MDM2—muscle cancer	9.86e-05	0.000377	CbGpPWpGaD
Adenosine triphosphate—AKT1—Apoptosis—TP53—muscle cancer	9.8e-05	0.000375	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—PTCH1—muscle cancer	9.68e-05	0.00037	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Innate Immune System—FOXO1—muscle cancer	9.64e-05	0.000369	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Disease—FOXO1—muscle cancer	9.56e-05	0.000366	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Neuronal System—MDM2—muscle cancer	9.47e-05	0.000362	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by FGFR in disease—MDM2—muscle cancer	9.41e-05	0.00036	CbGpPWpGaD
Adenosine triphosphate—AKT1—DAP12 interactions—MDM2—muscle cancer	9.41e-05	0.00036	CbGpPWpGaD
Adenosine triphosphate—AKT1—Fc epsilon receptor (FCERI) signaling—MDM2—muscle cancer	9.41e-05	0.00036	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—GPCR downstream signaling—CNR1—muscle cancer	9.38e-05	0.000359	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by EGFR—MDM2—muscle cancer	9.33e-05	0.000357	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—IGF2—muscle cancer	9.32e-05	0.000357	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by EGFR in Cancer—MDM2—muscle cancer	9.25e-05	0.000354	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by PDGF—MDM2—muscle cancer	9.21e-05	0.000352	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—KIDINS220—muscle cancer	9.18e-05	0.000351	CbGpPWpGaD
Adenosine triphosphate—ABL1—Retinoblastoma (RB) in Cancer—TP53—muscle cancer	9.04e-05	0.000346	CbGpPWpGaD
Adenosine triphosphate—ADCY1—GPCR downstream signaling—CNR1—muscle cancer	9e-05	0.000344	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—ENO2—muscle cancer	8.98e-05	0.000344	CbGpPWpGaD
Adenosine triphosphate—AKT1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	8.86e-05	0.000339	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—FH—muscle cancer	8.85e-05	0.000339	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Circadian rythm related genes—TP53—muscle cancer	8.74e-05	0.000334	CbGpPWpGaD
Adenosine triphosphate—AKT1—B Cell Activation—MDM2—muscle cancer	8.71e-05	0.000333	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—ENO2—muscle cancer	8.61e-05	0.00033	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—FOXO1—muscle cancer	8.58e-05	0.000328	CbGpPWpGaD
Adenosine triphosphate—AKT1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	8.54e-05	0.000327	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—CNR1—muscle cancer	8.52e-05	0.000326	CbGpPWpGaD
Adenosine triphosphate—ABL2—Developmental Biology—VEGFA—muscle cancer	8.44e-05	0.000323	CbGpPWpGaD
Adenosine triphosphate—HSPA1B—Disease—KIT—muscle cancer	8.44e-05	0.000323	CbGpPWpGaD
Adenosine triphosphate—ABL1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	8.4e-05	0.000321	CbGpPWpGaD
Adenosine triphosphate—ABCA1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	8.35e-05	0.00032	CbGpPWpGaD
Adenosine triphosphate—AKT1—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	8.34e-05	0.000319	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—FOXO4—muscle cancer	8.25e-05	0.000316	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	8.17e-05	0.000313	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—CNR1—muscle cancer	8.17e-05	0.000313	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—HMGA1—muscle cancer	8.17e-05	0.000312	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by NGF—KIT—muscle cancer	8.14e-05	0.000312	CbGpPWpGaD
Adenosine triphosphate—AKT1—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	8.12e-05	0.000311	CbGpPWpGaD
Adenosine triphosphate—ABL1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	8.09e-05	0.00031	CbGpPWpGaD
Adenosine triphosphate—AKT1—DNA Damage Response (only ATM dependent)—TP53—muscle cancer	7.96e-05	0.000305	CbGpPWpGaD
Adenosine triphosphate—ABL1—Cell Cycle—TP53—muscle cancer	7.96e-05	0.000304	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—FOXO4—muscle cancer	7.93e-05	0.000304	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—FOXO4—muscle cancer	7.92e-05	0.000303	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—MED12—muscle cancer	7.91e-05	0.000303	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—HMGA1—muscle cancer	7.83e-05	0.0003	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—FOXO4—muscle cancer	7.82e-05	0.000299	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Disease—KIT—muscle cancer	7.79e-05	0.000298	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Circadian rythm related genes—TP53—muscle cancer	7.72e-05	0.000295	CbGpPWpGaD
Adenosine triphosphate—ABL1—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	7.69e-05	0.000294	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Innate Immune System—KIT—muscle cancer	7.66e-05	0.000293	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—FOXO4—muscle cancer	7.61e-05	0.000291	CbGpPWpGaD
Adenosine triphosphate—ABL1—DNA Damage Response (only ATM dependent)—TP53—muscle cancer	7.55e-05	0.000289	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—IGF2—muscle cancer	7.36e-05	0.000281	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Innate Immune System—KIT—muscle cancer	7.35e-05	0.000281	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—FOXO4—muscle cancer	7.32e-05	0.00028	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Disease—KIT—muscle cancer	7.29e-05	0.000279	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—MED12—muscle cancer	7.24e-05	0.000277	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—ENO2—muscle cancer	7.21e-05	0.000276	CbGpPWpGaD
Adenosine triphosphate—ABCG1—Metabolism—PTGS2—muscle cancer	7.08e-05	0.000271	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CD34—muscle cancer	7.07e-05	0.000271	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—FOXO4—muscle cancer	7.02e-05	0.000269	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—IGF2—muscle cancer	6.97e-05	0.000267	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—FOXO1—muscle cancer	6.9e-05	0.000264	CbGpPWpGaD
Adenosine triphosphate—AKT1—TGF-beta Signaling Pathway—TP53—muscle cancer	6.83e-05	0.000261	CbGpPWpGaD
Adenosine triphosphate—AKT1—Focal Adhesion—VEGFA—muscle cancer	6.75e-05	0.000258	CbGpPWpGaD
Adenosine triphosphate—AKT1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	6.73e-05	0.000257	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—CD34—muscle cancer	6.7e-05	0.000256	CbGpPWpGaD
Adenosine triphosphate—HSPA1B—Disease—MDM2—muscle cancer	6.65e-05	0.000254	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—ENO2—muscle cancer	6.6e-05	0.000252	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—FOXO1—muscle cancer	6.54e-05	0.00025	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—KIT—muscle cancer	6.54e-05	0.00025	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—PTCH1—muscle cancer	6.47e-05	0.000248	CbGpPWpGaD
Adenosine triphosphate—ABCB1—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	6.43e-05	0.000246	CbGpPWpGaD
Adenosine triphosphate—AKT1—Gene Expression—MED12—muscle cancer	6.43e-05	0.000246	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by NGF—MDM2—muscle cancer	6.41e-05	0.000245	CbGpPWpGaD
Adenosine triphosphate—HSPA1B—Disease—PTGS2—muscle cancer	6.41e-05	0.000245	CbGpPWpGaD
Adenosine triphosphate—ABL1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	6.38e-05	0.000244	CbGpPWpGaD
Adenosine triphosphate—ABL1—Factors involved in megakaryocyte development and platelet production—TP53—muscle cancer	6.32e-05	0.000242	CbGpPWpGaD
Adenosine triphosphate—NT5C2—Metabolism—PTGS2—muscle cancer	6.31e-05	0.000241	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Disease—MDM2—muscle cancer	6.13e-05	0.000235	CbGpPWpGaD
Adenosine triphosphate—AKT1—Integrated Breast Cancer Pathway—TP53—muscle cancer	6.13e-05	0.000235	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—PTCH1—muscle cancer	6.12e-05	0.000234	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—FOXO1—muscle cancer	6.09e-05	0.000233	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Innate Immune System—MDM2—muscle cancer	6.04e-05	0.000231	CbGpPWpGaD
Adenosine triphosphate—AKT1—Apoptosis—TP53—muscle cancer	6.01e-05	0.00023	CbGpPWpGaD
Adenosine triphosphate—AKT1—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	5.98e-05	0.000229	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—PTCH1—muscle cancer	5.96e-05	0.000228	CbGpPWpGaD
Adenosine triphosphate—ACSS1—Metabolism—PTGS2—muscle cancer	5.93e-05	0.000227	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Disease—PTGS2—muscle cancer	5.91e-05	0.000226	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—FOXO1—muscle cancer	5.86e-05	0.000224	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—FOXO1—muscle cancer	5.85e-05	0.000224	CbGpPWpGaD
Adenosine triphosphate—ABL1—Integrated Breast Cancer Pathway—TP53—muscle cancer	5.81e-05	0.000222	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Innate Immune System—MDM2—muscle cancer	5.79e-05	0.000221	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—FOXO1—muscle cancer	5.78e-05	0.000221	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Disease—MDM2—muscle cancer	5.74e-05	0.00022	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—MED12—muscle cancer	5.72e-05	0.000219	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—PTCH1—muscle cancer	5.72e-05	0.000219	CbGpPWpGaD
Adenosine triphosphate—AKT1—GPCR downstream signaling—CNR1—muscle cancer	5.69e-05	0.000218	CbGpPWpGaD
Adenosine triphosphate—AKT1—MAPK Signaling Pathway—TP53—muscle cancer	5.63e-05	0.000215	CbGpPWpGaD
Adenosine triphosphate—ACSS2—Metabolism—PTGS2—muscle cancer	5.63e-05	0.000215	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—FOXO1—muscle cancer	5.62e-05	0.000215	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Allograft Rejection—VEGFA—muscle cancer	5.57e-05	0.000213	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—FOXO4—muscle cancer	5.57e-05	0.000213	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Disease—PTGS2—muscle cancer	5.53e-05	0.000212	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—CNR1—muscle cancer	5.46e-05	0.000209	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—ENO2—muscle cancer	5.44e-05	0.000208	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—FOXO1—muscle cancer	5.41e-05	0.000207	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—ENO2—muscle cancer	5.22e-05	0.0002	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—FOXO1—muscle cancer	5.19e-05	0.000198	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—CNR1—muscle cancer	5.16e-05	0.000198	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—MDM2—muscle cancer	5.15e-05	0.000197	CbGpPWpGaD
Adenosine triphosphate—ASS1—Metabolism—PTGS2—muscle cancer	5.14e-05	0.000197	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—FOXO4—muscle cancer	5.13e-05	0.000196	CbGpPWpGaD
Adenosine triphosphate—AKT1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	5.08e-05	0.000194	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CNR1—muscle cancer	5.03e-05	0.000193	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—MED12—muscle cancer	5e-05	0.000191	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—HMGA1—muscle cancer	4.95e-05	0.000189	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—FOXO4—muscle cancer	4.92e-05	0.000188	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CNR1—muscle cancer	4.83e-05	0.000185	CbGpPWpGaD
Adenosine triphosphate—ABL1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	4.82e-05	0.000184	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—FOXO4—muscle cancer	4.81e-05	0.000184	CbGpPWpGaD
Adenosine triphosphate—ADK—Metabolism—PTGS2—muscle cancer	4.78e-05	0.000183	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—KIT—muscle cancer	4.64e-05	0.000178	CbGpPWpGaD
Adenosine triphosphate—ACSL1—Metabolism—PTGS2—muscle cancer	4.63e-05	0.000177	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Metabolism—PTGS2—muscle cancer	4.63e-05	0.000177	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—ENO2—muscle cancer	4.56e-05	0.000174	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—FOXO4—muscle cancer	4.56e-05	0.000174	CbGpPWpGaD
Adenosine triphosphate—ASNS—Metabolism—PTGS2—muscle cancer	4.5e-05	0.000172	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—IGF2—muscle cancer	4.47e-05	0.000171	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—KIT—muscle cancer	4.46e-05	0.000171	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—KIT—muscle cancer	4.46e-05	0.000171	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—FOXO4—muscle cancer	4.44e-05	0.00017	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—KIT—muscle cancer	4.4e-05	0.000168	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—KIT—muscle cancer	4.28e-05	0.000164	CbGpPWpGaD
Adenosine triphosphate—ABL1—Axon guidance—VEGFA—muscle cancer	4.18e-05	0.00016	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—KIT—muscle cancer	4.12e-05	0.000158	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—IGF2—muscle cancer	4.12e-05	0.000157	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—FOXO1—muscle cancer	4.11e-05	0.000157	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	4.08e-05	0.000156	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—KIT—muscle cancer	3.95e-05	0.000151	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—IGF2—muscle cancer	3.95e-05	0.000151	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—VEGFA—muscle cancer	3.91e-05	0.00015	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—FOXO1—muscle cancer	3.79e-05	0.000145	CbGpPWpGaD
Adenosine triphosphate—ABCA1—Metabolism—PTGS2—muscle cancer	3.72e-05	0.000142	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—MDM2—muscle cancer	3.66e-05	0.00014	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—FOXO1—muscle cancer	3.63e-05	0.000139	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	3.62e-05	0.000139	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—FH—muscle cancer	3.62e-05	0.000138	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—PTCH1—muscle cancer	3.61e-05	0.000138	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—FOXO1—muscle cancer	3.55e-05	0.000136	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—MDM2—muscle cancer	3.52e-05	0.000135	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—MDM2—muscle cancer	3.51e-05	0.000134	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	3.49e-05	0.000134	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—MDM2—muscle cancer	3.47e-05	0.000133	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—MDM2—muscle cancer	3.37e-05	0.000129	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—FOXO1—muscle cancer	3.37e-05	0.000129	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—FOXO1—muscle cancer	3.28e-05	0.000125	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—MDM2—muscle cancer	3.25e-05	0.000124	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—VEGFA—muscle cancer	3.14e-05	0.00012	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—KIT—muscle cancer	3.13e-05	0.00012	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—PTGS2—muscle cancer	3.13e-05	0.00012	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—MDM2—muscle cancer	3.11e-05	0.000119	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—FOXO4—muscle cancer	3.11e-05	0.000119	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—VEGFA—muscle cancer	3.08e-05	0.000118	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CNR1—muscle cancer	3.05e-05	0.000117	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—PTGS2—muscle cancer	3e-05	0.000115	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—VEGFA—muscle cancer	2.98e-05	0.000114	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—TP53—muscle cancer	2.95e-05	0.000113	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—VEGFA—muscle cancer	2.92e-05	0.000112	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—KIT—muscle cancer	2.89e-05	0.00011	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—KIT—muscle cancer	2.77e-05	0.000106	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	2.75e-05	0.000105	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—KIT—muscle cancer	2.7e-05	0.000103	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—KIT—muscle cancer	2.56e-05	9.81e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Metabolism—PTGS2—muscle cancer	2.51e-05	9.61e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—KIT—muscle cancer	2.5e-05	9.56e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—IGF2—muscle cancer	2.49e-05	9.54e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—MDM2—muscle cancer	2.47e-05	9.44e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—TP53—muscle cancer	2.33e-05	8.92e-05	CbGpPWpGaD
Adenosine triphosphate—ABCC8—Metabolism—PTGS2—muscle cancer	2.3e-05	8.79e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—FOXO1—muscle cancer	2.29e-05	8.78e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—MDM2—muscle cancer	2.27e-05	8.7e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—TP53—muscle cancer	2.21e-05	8.45e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—MDM2—muscle cancer	2.18e-05	8.34e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—MDM2—muscle cancer	2.13e-05	8.15e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	2.08e-05	7.95e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—MED12—muscle cancer	2.04e-05	7.82e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—MDM2—muscle cancer	2.02e-05	7.73e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—MDM2—muscle cancer	1.97e-05	7.53e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—PTGS2—muscle cancer	1.9e-05	7.25e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—VEGFA—muscle cancer	1.87e-05	7.17e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—ENO2—muscle cancer	1.86e-05	7.13e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB11—Metabolism—PTGS2—muscle cancer	1.82e-05	6.95e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—KIT—muscle cancer	1.75e-05	6.69e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—VEGFA—muscle cancer	1.73e-05	6.6e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—VEGFA—muscle cancer	1.65e-05	6.33e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Metabolism—PTGS2—muscle cancer	1.59e-05	6.08e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—TP53—muscle cancer	1.42e-05	5.42e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—MDM2—muscle cancer	1.38e-05	5.27e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—TP53—muscle cancer	1.3e-05	4.99e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—TP53—muscle cancer	1.25e-05	4.78e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—VEGFA—muscle cancer	1.05e-05	4e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—TP53—muscle cancer	7.9e-06	3.02e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—PTGS2—muscle cancer	6.49e-06	2.48e-05	CbGpPWpGaD
